1. Home
  2. HURA vs HFFG Comparison

HURA vs HFFG Comparison

Compare HURA & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURA
  • HFFG
  • Stock Information
  • Founded
  • HURA 2009
  • HFFG 1997
  • Country
  • HURA United States
  • HFFG United States
  • Employees
  • HURA N/A
  • HFFG N/A
  • Industry
  • HURA
  • HFFG Food Distributors
  • Sector
  • HURA
  • HFFG Consumer Discretionary
  • Exchange
  • HURA Nasdaq
  • HFFG Nasdaq
  • Market Cap
  • HURA 131.8M
  • HFFG 124.7M
  • IPO Year
  • HURA N/A
  • HFFG N/A
  • Fundamental
  • Price
  • HURA $2.12
  • HFFG $2.23
  • Analyst Decision
  • HURA Strong Buy
  • HFFG
  • Analyst Count
  • HURA 2
  • HFFG 0
  • Target Price
  • HURA $11.50
  • HFFG N/A
  • AVG Volume (30 Days)
  • HURA 179.3K
  • HFFG 89.4K
  • Earning Date
  • HURA 11-14-2025
  • HFFG 11-10-2025
  • Dividend Yield
  • HURA N/A
  • HFFG N/A
  • EPS Growth
  • HURA N/A
  • HFFG N/A
  • EPS
  • HURA N/A
  • HFFG N/A
  • Revenue
  • HURA N/A
  • HFFG $1,225,541,000.00
  • Revenue This Year
  • HURA N/A
  • HFFG $4.27
  • Revenue Next Year
  • HURA N/A
  • HFFG $4.55
  • P/E Ratio
  • HURA N/A
  • HFFG N/A
  • Revenue Growth
  • HURA N/A
  • HFFG 4.10
  • 52 Week Low
  • HURA $1.80
  • HFFG $1.70
  • 52 Week High
  • HURA $7.20
  • HFFG $4.93
  • Technical
  • Relative Strength Index (RSI)
  • HURA 32.79
  • HFFG 40.26
  • Support Level
  • HURA $2.01
  • HFFG $2.20
  • Resistance Level
  • HURA $2.60
  • HFFG $2.42
  • Average True Range (ATR)
  • HURA 0.15
  • HFFG 0.15
  • MACD
  • HURA -0.04
  • HFFG 0.03
  • Stochastic Oscillator
  • HURA 8.84
  • HFFG 42.65

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

Share on Social Networks: